Therapeutic advances in psychopharmacology

Using MDMA-assisted therapy for borderline personality disorder and complex PTSD: a summary of existing studies

Updated

Abstract

MDMA-assisted psychotherapy (MDMA-AP) has demonstrated considerable efficacy in treating post-traumatic stress disorder (PTSD).

  • PTSD and complex PTSD (CPTSD) frequently co-occur with borderline personality disorder (BPD).
  • BPD is characterized by emotional dysregulation, interpersonal difficulties, and fears of abandonment.
  • BPD often includes suicidal and non-suicidal self-injury.
  • MDMA-AP is hypothesized to be effective for BPD, but its application to CPTSD and BPD has not been systematically reviewed.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors declare that there is no conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free